Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of weight-loss on estimated breast-cancer risk and sex-hormone levels.

Oncology reports·2011
Same author

Cancer-patients - the survival and expense of traditional care and hospice care.

Oncology reports·2011
Same author

DES-ja vu.

Oncology reports·2011
Same author

Early stage breast cancer.

Oncology reports·2011
Same author

Heroic measures when treating patients with hematologic malignancies - the economic cost of survival.

International journal of oncology·2011
Same author

Evaluation of a frozen section protocol in endometrial carcinoma.

International journal of oncology·2011
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 2, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Prostate-cancer surveillance - a cost-effective strategy.

D Schapira1, A Jarrett

  • 1UNIV S FLORIDA,COLL MED,TAMPA,FL 33612.

International Journal of Oncology
|May 17, 2011
PubMed
Summary

Monitoring prostate cancer patients aims to detect recurrence early. Eliminating costly, less sensitive tests like bone scans and prostatic acid phosphatase from surveillance programs can save billions annually.

Area of Science:

  • Oncology
  • Health Economics

Background:

  • Prostate cancer surveillance is crucial for early detection of recurrence.
  • Current surveillance programs often include multiple tests, increasing costs.

Purpose of the Study:

  • To analyze the cost-effectiveness of different prostate cancer surveillance programs.
  • To determine the clinical utility of various tests in monitoring disease recurrence.

Main Methods:

  • Comparative analysis of four distinct prostate cancer surveillance strategies.
  • Evaluation of Prostate-Specific Antigen (PSA) levels versus bone scans, prostatic acid phosphatase, and alkaline phosphatase.

Main Results:

  • Prostate-Specific Antigen (PSA) levels are more sensitive for detecting recurrence than bone scans, prostatic acid phosphatase, and alkaline phosphatase.

More Related Videos

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Related Experiment Videos

Last Updated: Jun 2, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

  • Including less sensitive tests in surveillance programs provides no additional clinically useful information beyond PSA monitoring.
  • Eliminating these redundant tests from surveillance programs could significantly reduce healthcare expenses.

    • Conclusions:

    • A surveillance program solely based on Prostate-Specific Antigen (PSA) levels is clinically effective and cost-efficient for prostate cancer monitoring.
    • Removing bone scans, prostatic acid phosphatase, and alkaline phosphatase from prostate cancer surveillance protocols can lead to substantial national cost savings.